Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells.
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
RAGE-ligand axis: A new biomarker in multiple sclerosis, time for multicentre validation study!
The importance of collecting structured clinical information on multiple sclerosis.
Commentary: Acute Hemorrhagic Leukoencephalitis (Weston-Hurst Syndrome) in a Patient with Relapse-Remitting Multiple Sclerosis.
Progressive Multiple Sclerosis.
The redesign of consumer cost sharing for specialty drugs at the California Health Insurance Exchange.
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
Functional Predictors Of Physical Activity Levels In Patients With Multiple Sclerosis: 2571 Board #94 June 3, 9: 30 AM - 11: 00 AM.
Mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adults.
Theoretical predication of temperature effect on conducting processes in simulated amyotrophic lateral sclerosis at 20-40[Formula: see text]C.
Gut microbiome analysis in neuromyelitis optica reveals over-abundance of Clostridium perfringens.
Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the Future.
Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF.
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity.
ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis.
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.
Fatigue in Multiple Sclerosis: Misconceptions and Future Research Directions.
Cervical demyelinating lesion presenting with choreoathetoid movements and dystonia.
Evaluation of pulsing magnetic field effects on paresthesia in multiple sclerosis patients, a randomized, double-blind, parallel-group clinical trial.
Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.
Association of CD40 Gene Polymorphisms with Susceptibility to Neuromyelitis Optica Spectrum Disorders.
Association Between Intellectual Capacity And Fatigue In Persons With Multiple Sclerosis: 1292 Board #4 June 2, 8: 00 AM - 10: 00 AM.
Aescin reduces oxidative stress and provides neuroprotection in experimental traumatic spinal cord injury.
Pages
« first
‹ previous
…
842
843
844
845
846
847
848
849
850
…
next ›
last »